Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease

Brain Research

Volumn 1394, Issue , 2011, Pages 105-111

  Wu, Guanghua ^a   Wang, Xuenan ^a   Feng, Xungang ^a   Zhang, Aimei ^a   Li, Jifeng ^a   Gu, Kejin ^a   Huang, Jian ^a   Pang, Shuchao ^a   Dong, Haixin ^a   Gao, Huijie ^a   Yan, Bo ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; LAMP 2; LC3; Leukocytes; Lysosome; Parkinson's disease

Indexed keywords

CHAPERONE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MICROTUBULE ASSOCIATED PROTEIN 1;

ADULT; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYSOSOME; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AUTOPHAGY; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOLECULAR CHAPERONES; PARKINSON DISEASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 79956275976     PISSN: 00068993     EISSN: 00068993     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.04.013     Document Type: Article

References (64)

1. Aharon-Peretz, J., Rosenbaum, H., Gershoni-Baruch, R., 2004. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 351, 1972-1977.
2. Alegre-Abarrategui, J., Christian, H., Lufino, M.M., Mutihac, R., Venda, L.L., Ansorge, O., Wade-Martins, R., 2009. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 18, 4022-4034.
3. Alvarez-Erviti, L., Rodriguez-Oroz, M.C., Cooper, J.M., Caballero, C., Ferrer, I., Obeso, J.A., Schapira, A.H., 2010. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 67, 1464-1472.
4. Anglade, P., Vyas, S., Javoy-Agid, F., Michel, P.P., Marquez, J., Mouatt-Prigent, A., Ruberg, M., Hirsch, E.C., Agid, Y., 1997. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31.
5. Bandopadhyay, R., de Belleroche, J., 2010. Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. Trends Mol. Med. 16, 27-36.
6. Bandyopadhyay, U., Cuervo, A.M., 2007. Chaperone-mediated autophagy in aging and neurodegeneration: lessons from alpha-synuclein. Exp. Gerontol. 42, 120-128.
7. Banerjee, R., Beal, M.F., Thomas, B., 2010. Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 33, 541-549.
8. Castino, R., Lazzeri, G., Lenzi, P., Bellio, N., Follo, C., Ferrucci, M., Fornai, F., Isidoro, C., 2008. Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine. J. Neurochem. 106, 1426-1439.
9. Chartier-Harlin, M.C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., Waucquier, N., Defebvre, L., Amouyel, P., Farrer, M., Destée, A., 2004. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364, 1167-1169. (Pubitemid 39296604)
10. Chu, C.T., 2010. A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Hum. Mol. Genet. 19 (R1), R28-R37.
11. Cookson, M.R., Bandmann, O., 2010. Parkinson's disease: insights from pathways. Hum. Mol. Genet. 19 (R1), R21-R27.
12. Cuervo, A.M., Stefanis, L., Fredenburg, R., Lansbury, P.T., Sulzer, D., 2004. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295. (Pubitemid 39129234)
13. Dawson, T.M., Ko, H.S., Dawson, V.L., 2010. Genetic animal models of Parkinson's disease. Neuron 66, 646-661.
14. Di Fonzo, A., Chien, H.F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., Fabbrini, G., Marconi, R., Fincati, E., Abbruzzese, G., Marini, P., Squitieri, F., Horstink, M.W., Montagna, P., Libera, A.D., Stocchi, F., Goldwurm, S., Ferreira, J.J., Meco, G., Martignoni, E., Lopiano, L., Jardim, L.B., Oostra, B.A., Barbosa, E.R., Italian Parkinson Genetics Network, Bonifati, V., 2007. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68, 1557-1562.
15. Eriksen, J.L., Przedborski, S., Petrucelli, L., 2005. Gene dosage and pathogenesis of Parkinson's disease. TrendsMol.Med. 11, 91-96. (Pubitemid 40348985)
16. Eskelinen, E.L., Illert, A.L., Tanaka, Y., Schwarzmann, G., Blanz, J., Von Figura, K., Saftig, P., 2002. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol. Biol. Cell 13, 3355-3368.
17. Eskelinen, E.L., Saftig, P., 2009. Autophagy: a lysosomal degradation pathway with a central role in health and disease. Biochim. Biophys. Acta 1793, 664-673.
18. Farrer, M., Maraganore, D.M., Lockhart, P., Singleton, A., Lesnick, T.G., de Andrade, M., West, A., de Silva, R., Hardy, J., Hernandez, D., 2001. alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet. 10, 1847-1851.
19. Ferrucci, M., Pasquali, L., Ruggieri, S., Paparelli, A., Fornai, F., 2008. Alpha-synuclein and autophagy as common steps in neurodegeneration. Parkinsonism Relat. Disord. 14 (Suppl 2), S180-S184.
20. Fukuda, M., Viitala, J., Matteson, J., Carlsson, S.R., 1988. Cloning of cDNAs encoding human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Comparison of their deduced amino acid sequences. J. Biol. Chem. 263, 18920-18928.
21. Hardy, J., 2010. Genetic analysis of pathways to Parkinson disease. Neuron 68, 201-206.
22. He, C., Klionsky, D.J., 2009. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67-93.
23. Ibáñez, P., Bonnet, A.M., Débarges, B., Lohmann, E., Tison, F., Pollak, P., Agid, Y., Dürr, A., Brice, A., 2004. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 364, 1169-1171. (Pubitemid 39296605)
24. Isidoro, C., Biagioni, F., Giorgi, F.S., Fulceri, F., Paparelli, A., Fornai, F., 2009. The role of autophagy on the survival of dopamine neurons. Curr. Top. Med. Chem. 9, 869-879.
25. Kabuta, T., Furuta, A., Aoki, S., Furuta, K., Wada, K., 2008. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J. Biol. Chem. 283, 23731-23738.
26. Klionsky, D.J., Abeliovich, H., Agostinis, P., Agrawal, D.K., Aliev, G., Askew, D.S., et al., 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175. (Pubitemid 351231180)
27. Klionsky, D.J., 2007. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8, 931-937.
28. Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J.T., Schöls, L., Riess, O., 1998. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
29. Lee, H.J., Khoshaghideh, F., Patel, S., Lee, S.J., 2004. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 24, 1888-1896. (Pubitemid 38292800)
30. Lees, A.J., Hardy, J., Revesz, T., 2009. Parkinson's disease. Lancet 373, 2055-2066.
31. Lesage, S., Brice, A., 2009. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18 (R1), R48-R59.
32. Mak, S.K., McCormack, A.L., Manning-Bog, A.B., Cuervo, A.M., Di Monte, D.A., 2010. Lysosomal degradation of alpha-synuclein in vivo. J. Biol. Chem. 285, 13621-13629.
33. Maraganore, D.M., de Andrade, M., Elbaz, A., Farrer, M.J., Ioannidis, J.P., Krüger, R., Rocca, W.A., Schneider, N.K., Lesnick, T.G., Lincoln, S.J., Hulihan, M.M., Aasly, J.O., Ashizawa, T., Chartier-Harlin, M.C., Checkoway, H., Ferrarese, C., Hadjigeorgiou, G., Hattori, N., Kawakami, H., Lambert, J.C., Lynch, T., Mellick, G.D., Papapetropoulos, S., Parsian, A., Quattrone, A., Riess, O., Tan, E.K., Van Broeckhoven, C., Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium, 2006. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296, 661-670.
34. Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A.C., Mazzulli, J., Mosharov, E.V., Hodara, R., Fredenburg, R., Wu, D.C., Follenzi, A., Dauer, W., Przedborski, S., Ischiropoulos, H., Lansbury, P.T., Sulzer, D., Cuervo, A.M., 2008. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118, 777-788.
35. Massey, A.C., Kaushik, S., Sovak, G., Kiffin, R., Cuervo, A.M., 2006. Consequences of the selective blockage of chaperone-mediated autophagy. Proc. Natl. Acad. Sci. USA 103, 5805-5810.
36. Mattei, M.G., Matterson, J., Chen, J.W., Williams, M.A., Fukuda, M., 1990. Two human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2, are encoded by genes localized to chromosome 13q34 and chromosome Xq24-25, respectively. J. Biol. Chem. 265, 7548-7551.
37. Meredith, G.E., Totterdell, S., Petroske, E., Santa Cruz, K., Callison Jr., R.C., Lau, Y.S., 2002. Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res. 956, 156-165. (Pubitemid 35335568)
38. Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J., 2008. Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075. (Pubitemid 351317450)
39. Moore, D.J., West, A.B., Dawson, V.L., Dawson, T.M., 2005. Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. 28, 57-87.
40. Narendra, D., Tanaka, A., Suen, D.F., Youle, R.J., 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795-803.
41. Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., et al., 2000. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406, 906-910. (Pubitemid 30664268)
42. Pan, T., Kondo, S., Le, W., Jankovic, J., 2008. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 131 (Pt 8), 1969-1978.
43. Pasquali, L., Ruggieri, S., Murri, L., Paparelli, A., Fornai, F., 2009. Does autophagy worsen or improve the survival of dopaminergic neurons? Parkinsonism Relat. Disord. 15 (Suppl 4), S24-S27.
44. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I., Nussbaum, R.L., 1997. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. (Pubitemid 27443610)
45. Prigione, A., Piazza, F., Brighina, L., Begni, B., Galbussera, A., Difrancesco, J.C., Andreoni, S., Piolti, R., Ferrarese, C., 2010. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease. Neurosci. Lett. 477, 6-10.
46. Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L.P., Goebel, I., Mubaidin, A.F., Wriekat, A.L., Roeper, J., Al-Din, A., Hillmer, A.M., Karsak, M., Liss, B., Woods, C.G., Behrens, M.I., Kubisch, C., 2006. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191.
47. Ruivo, R., Anne, C., Sagné, C., Gasnier, B., 2009. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim. Biophys. Acta 1793, 636-649.
48. Sawada, R., Jardine, K.A., Fukuda, M., 1993. The genes of major lysosomal membrane glycoproteins, lamp-1 and lamp-2. 5′-flanking sequence of lamp-2 gene and comparison of exon organization in two genes. J. Biol. Chem. 268, 9014-9022.
49. Sidransky, E., Nalls, M.A., Aasly, J.O., Aharon-Peretz, J., Annesi, G., Barbosa, E.R., et al., 2009. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 361, 1651-1661.
50. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M.R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., Gwinn-Hardy, K., 2003. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841. (Pubitemid 37339619)
51. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., 1997. Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
52. Thomas, B., Beal, M.F., 2007. Parkinson's disease. Hum. Mol. Genet. 16 (Spec No. 2), R183-R194.
53. Vogiatzi, T., Xilouri, M., Vekrellis, K., Stefanis, L., 2008.Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J. Biol. Chem. 283, 23542-23556.
54. Webb, J.L., Ravikumar, B., Atkins, J., Skepper, J.N., Rubinsztein, D.C., 2003. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009-25013.
55. Winkler, S., Hagenah, J., Lincoln, S., Heckman, M., Haugarvoll, K., Lohmann-Hedrich, K., Kostic, V., Farrer, M., Klein, C., 2007. alpha-Synuclein and Parkinson disease susceptibility. Neurology 69, 1745-1750.
56. Winklhofer, K.F., Haass, C., 2010. Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 1802, 29-44.
57. Winslow, A.R., Chen, C.W., Corrochano, S., Acevedo-Arozena, A., Gordon, D.E., Peden, A.A., Lichtenberg, M., Menzies, F.M., Ravikumar, B., Imarisio, S., Brown, S., O'Kane, C.J., Rubinsztein, D.C., 2010. α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 190, 1023-1037.
58. Wong, E., Cuervo, A.M., 2010. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 13, 805-811.
59. Xie, W., Wan, O.W., Chung, K.K., 2010. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease. Biochim. Biophys. Acta 1802, 935-941.
60. Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., Stefanis, L., 2009. Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4, e5515.
61. Xilouri, M., Vogiatzi, T., Vekrellis, K., Stefanis, L., 2008. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis. Autophagy 4, 917-919.
62. Yu, W.H., Dorado, B., Figueroa, H.Y., Wang, L., Planel, E., Cookson, M.R., Clark, L.N., Duff, K.E., 2009.Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein. Am. J. Pathol. 175, 736-747.
63. Zarranz, J.J., Alegre, J., Gómez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Muñoz, D.G., de Yebenes, J.G., 2004. The newmutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164-173.
64. Zhang, C., Cuervo, A.M., 2008. Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function. Nat. Med. 14, 959-965.